ATA157396A - Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen - Google Patents

Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen

Info

Publication number
ATA157396A
ATA157396A AT157396A AT157396A ATA157396A AT A157396 A ATA157396 A AT A157396A AT 157396 A AT157396 A AT 157396A AT 157396 A AT157396 A AT 157396A AT A157396 A ATA157396 A AT A157396A
Authority
AT
Austria
Prior art keywords
coist
disorders
pharmaceutical preparation
treating blood
blood
Prior art date
Application number
AT157396A
Other languages
English (en)
Other versions
AT407116B (de
Inventor
Peter Dr Turecek
Hans-Peter Schwarz
Johann Dr Eibl
Original Assignee
Immuno Aktiengeselschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AT157396A priority Critical patent/AT407116B/de
Application filed by Immuno Aktiengeselschaft filed Critical Immuno Aktiengeselschaft
Priority to CZ97819A priority patent/CZ81997A3/cs
Priority to SI9730711T priority patent/SI0796623T1/xx
Priority to ES97890051T priority patent/ES2241030T3/es
Priority to EP97890051A priority patent/EP0796623B1/de
Priority to AT97890051T priority patent/ATE296109T1/de
Priority to HU9700603A priority patent/HUP9700603A3/hu
Priority to DK97890051T priority patent/DK0796623T3/da
Priority to DE59712322T priority patent/DE59712322D1/de
Priority to CA002200394A priority patent/CA2200394A1/en
Priority to AU16451/97A priority patent/AU725442B2/en
Priority to US08/821,763 priority patent/US5866122A/en
Priority to JP9108013A priority patent/JPH1045620A/ja
Priority to US09/165,745 priority patent/US6039945A/en
Priority to US09/244,762 priority patent/US6099837A/en
Priority to US09/245,339 priority patent/US6165974A/en
Priority to US09/521,219 priority patent/US6224862B1/en
Publication of ATA157396A publication Critical patent/ATA157396A/de
Priority to AU71856/00A priority patent/AU763466B2/en
Application granted granted Critical
Publication of AT407116B publication Critical patent/AT407116B/de
Priority to AU2003204479A priority patent/AU2003204479B2/en

Links

AT157396A 1996-03-20 1996-09-04 Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen AT407116B (de)

Priority Applications (19)

Application Number Priority Date Filing Date Title
AT157396A AT407116B (de) 1996-09-04 1996-09-04 Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen
DE59712322T DE59712322D1 (de) 1996-03-20 1997-03-18 Pharmazeutisches Präparat zur Behandlung von Blutgerinnungsstörungen
SI9730711T SI0796623T1 (en) 1996-03-20 1997-03-18 Pharmaceutical preparation for the treatment of blood coagulation disorders
ES97890051T ES2241030T3 (es) 1996-03-20 1997-03-18 Preparado farmaceutico para el tratamiento de alteraciones de la coagulacion sanguinea.
EP97890051A EP0796623B1 (de) 1996-03-20 1997-03-18 Pharmazeutisches Präparat zur Behandlung von Blutgerinnungsstörungen
AT97890051T ATE296109T1 (de) 1996-03-20 1997-03-18 Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen
HU9700603A HUP9700603A3 (en) 1996-03-20 1997-03-18 Pharmaceutical preparation for the treatment of blood coagulation disorders
DK97890051T DK0796623T3 (da) 1996-03-20 1997-03-18 Farmaceutisk præparat til behandling af blodkoagulationslidelser
CZ97819A CZ81997A3 (en) 1996-03-20 1997-03-18 Pharmaceutical preparation for treating disorders connected with blood clotting, process of its preparation and use
CA002200394A CA2200394A1 (en) 1996-03-20 1997-03-19 A pharmaceutical preparation for treating blood coagulation disorders
US08/821,763 US5866122A (en) 1996-03-20 1997-03-20 Pharmaceutical preparation for treating blood coagulation disorders
AU16451/97A AU725442B2 (en) 1996-03-20 1997-03-20 A pharmaceutical preparation for treating blood coagulation disorders
JP9108013A JPH1045620A (ja) 1996-03-20 1997-03-21 血液凝固疾患処置用医薬製剤
US09/165,745 US6039945A (en) 1996-03-20 1998-10-06 Pharmaceutical preparation for treating blood coagulation disorders
US09/244,762 US6099837A (en) 1996-03-20 1999-02-05 Pharmaceutical preparation for treating blood coagulation disorders
US09/245,339 US6165974A (en) 1996-03-20 1999-02-05 Pharmaceutical preparation for treating blood coagulation disorders
US09/521,219 US6224862B1 (en) 1996-03-20 2000-03-08 Pharmaceutical preparation for treating blood coagulation disorders
AU71856/00A AU763466B2 (en) 1996-03-20 2000-11-24 A pharmaceutical preparation for treating blood coagulation disorders
AU2003204479A AU2003204479B2 (en) 1996-03-20 2003-06-02 A pharmaceutical preparation for treating blood coagulation disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT157396A AT407116B (de) 1996-09-04 1996-09-04 Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen

Publications (2)

Publication Number Publication Date
ATA157396A true ATA157396A (de) 2000-05-15
AT407116B AT407116B (de) 2000-12-27

Family

ID=3516346

Family Applications (1)

Application Number Title Priority Date Filing Date
AT157396A AT407116B (de) 1996-03-20 1996-09-04 Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen

Country Status (1)

Country Link
AT (1) AT407116B (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4142908C2 (de) * 1991-12-24 1994-02-10 Octapharma Ag Glarus Verfahren zur Herstellung eines virusinaktivierten Prothrombinkomplex-Konzentrats (PPSB)

Also Published As

Publication number Publication date
AT407116B (de) 2000-12-27

Similar Documents

Publication Publication Date Title
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
DE69710095D1 (de) Pharmazeutische zubereitung zur behandlung von diabetes
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
ATE224189T1 (de) Antikonvulsive sulfamatderivate zur behandlung von fettleibigkeit
ATE275383T1 (de) Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
DE69609868D1 (de) Neue steroidester zur behandlung von hauterkrankungen
DE60023873D1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE69939058D1 (de) Vorrichtung zur behandlung von peripheren gefässerkrankungen
DE69739303D1 (de) Vorrichtung zur thermischen behandlung von gewebe
DE69524682D1 (de) Mittel zur Behandlung von Wunden
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69630479D1 (de) Arzneimittel zur Behandlung von entzündlichen Herzkrankheiten
DE69812681D1 (de) Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia
ATA46794A (de) Einrichtung zur behandlung von hautzonen
ATE200863T1 (de) Indolinonverbindungen zur behandlung von krankheiten
DE69526437D1 (de) Transdermal verabreichbare zubereitung zur behandlung von störungen des harnlassens
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE69711311D1 (de) Vorrichtung zur thermischen Behandlung von Gewebe
DE69613386D1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
DE69506019D1 (de) Vorrichtung zur Behandlung von Schmerz
DE59812049D1 (de) Pharmazeutische zusammensetzung zur behandlung von schlaganfall und schädel-hirn-trauma
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
PC Change of the owner

Owner name: BAXALTA GMBH, CH

Effective date: 20160623

Owner name: BAXALTA INCORPORATED, US

Effective date: 20160623

MK07 Expiry

Effective date: 20160904